The Council for International Organizations of Medical Sciences (CIOMS) has issued a draft report detailing a set of best practices to guide the integration of artificial intelligence in pharmacovigilance (PV) activities.
The report highlights that a crucial factor for the success of AI in PV is the ability to link and analyze large volumes of diverse data from various sources, including electronic health records (EHRs), claims databases, registries, the Internet of Things (IoT), and connected devices.
Effectively utilizing health data can facilitate the faster development of new treatments, enhance patient outcomes, and lower healthcare costs. Additionally, this capability has the potential to reveal valuable and actionable insights that may not have been discovered otherwise.